Evolus Receives Regulatory Approval for Nuceiva® in Australia

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. PATH
5. DOCU
6. SPY
7. ASAN
8. CIEN
9. GWRE
10. CPB

Go back to Evolus Receives Regulatory Approval for Nuceiva® in Australia
(NASDAQ: EOLS) Delayed: 9.07 +0.02 (0.22%)
Previous Close $9.05    52 Week High $ 
Open $9.05    52 Week Low $ 
Day High $9.08    P/E N/A 
Day Low $8.99    EPS $ 
Volume 45,878